PUMA BIOTECHNOLOGY, INC. Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount of -$20.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2020-02-28.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherReconcilingItems · last filed 2020-02-28
- PUMA BIOTECHNOLOGY, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2017 was -$20.00K.
- PUMA BIOTECHNOLOGY, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2016 was -$113.00K.
- PUMA BIOTECHNOLOGY, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2015 was -$2.57M, a 472.61% decline from fiscal 2014.
- PUMA BIOTECHNOLOGY, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2014 was $690.00K.
| Period end | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month as first filed |
|---|---|---|
| 2017-12-31 | -$20.00K 10-K · filed 2020-02-28 | |
| 2016-12-31 | -$113.00K 10-K · filed 2019-03-01 | |
| 2015-12-31 | -$2.57M 10-K · filed 2018-03-09 | |
| 2014-12-31 | $690.00K 10-K · filed 2017-03-01 | -$3.01M 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |